| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.006 |